March 9, 2020 / 11:35 AM / a month ago

BRIEF-Avrobio Receives Orphan Drug Designation From U.S. FDA For AVR‑RD‑04 For Cystinosis

March 9 (Reuters) - AVROBIO Inc:

* AVROBIO RECEIVES ORPHAN DRUG DESIGNATION FROM U.S. FDA FOR AVR-RD-04 FOR CYSTINOSIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below